Kerendia Uses for Kidney and Heart Risk Reduction

Kerendia is the brand name for finerenone, a prescription medicine used to reduce certain kidney and cardiovascular risks in adults with chronic kidney disease associated with type 2 diabetes. In some countries, it may also be approved for specific forms of heart failure; its approved use can differ by location.

What Are Kerendia Uses?

Kerendia uses primarily relate to protecting kidney and heart health in adults who have chronic kidney disease (CKD) associated with type 2 diabetes. Kerendia contains finerenone, a nonsteroidal mineralocorticoid receptor antagonist. It is prescribed to lower the risk of worsening kidney function, kidney failure and certain cardiovascular complications in people who meet the clinical criteria for treatment.

Kerendia is not insulin, and it does not replace medicines used to control blood sugar. It is also not a diuretic, although it acts on a hormone pathway that influences salt balance, fluid regulation and inflammation. Instead, it is usually added to a broader care plan that may include healthy lifestyle measures, blood pressure treatment, glucose management and other medicines that support kidney protection.

Regulatory approvals vary between countries. In some settings, finerenone is additionally approved for adults with heart failure and a left ventricular ejection fraction of 40% or higher. A doctor can explain the approved indication in the patient’s country and whether it fits their individual health needs.

How Kerendia Works in the Body

Finerenone blocks the mineralocorticoid receptor, a receptor activated by the hormone aldosterone. When this pathway is overactive, it may contribute to inflammation and scarring in the kidneys, heart and blood vessels. These changes can be particularly relevant in people who have both type 2 diabetes and chronic kidney disease.

By selectively blocking this receptor, Kerendia may help reduce damaging processes that contribute to kidney function decline and cardiovascular disease. Its benefit develops as part of ongoing treatment rather than providing immediate symptom relief. Many people with early or moderate CKD feel well, so treatment is often intended to reduce future health risks rather than to treat noticeable symptoms.

Kerendia is generally used in addition to, rather than instead of, established kidney and cardiovascular care. This may include managing high blood pressure, maintaining appropriate blood glucose levels, avoiding tobacco and using other medicines recommended by the treating clinician. The exact combination depends on kidney function, heart health and any other medical conditions.

Who May Be Considered for Treatment?

A clinician may consider Kerendia for an adult with type 2 diabetes and chronic kidney disease, particularly when urine tests show albumin, a protein that can leak into the urine when the kidneys are damaged. Kidney function is commonly assessed with an estimated glomerular filtration rate (eGFR), while a urine albumin-to-creatinine ratio helps assess albumin loss.

Not everyone with diabetes or kidney disease needs this medicine. The decision depends on laboratory results, blood pressure, cardiovascular history, current medication plan and the likelihood of side effects. Kerendia should only be started and monitored by a qualified healthcare professional who can review these factors together.

People with diabetes-related kidney disease may also benefit from learning about the condition itself, including chronic kidney disease. Early assessment and consistent follow-up can help identify changes in kidney health before symptoms become prominent.

Kerendia may not be suitable for people with certain conditions, including adrenal insufficiency, or for people taking medicines that strongly affect how finerenone is processed by the body. The prescriber will check for these concerns before treatment begins.

Taking Kerendia and Monitoring Treatment

Kerendia is taken by mouth as prescribed. The dose and whether treatment can be started or continued depend on kidney function and blood potassium levels. Patients should take it consistently and should not change the dose, stop it or restart it after a break without discussing this with their clinician.

Blood tests are an essential part of safe treatment. A potassium blood test and kidney function assessment are usually performed before starting Kerendia and repeated after treatment begins or the dose changes. Further testing may be needed if the person becomes unwell, develops dehydration, starts another medicine or has a change in kidney function.

If a dose is missed, patients should follow the instructions given with their prescription or ask a pharmacist for guidance. They should not take an extra dose to make up for a missed one. It is also important to attend planned diabetes, blood pressure and kidney reviews, even when no symptoms are present.

A kidney specialist, diabetes specialist, cardiologist and primary care clinician may work together when needs are complex. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support assessment and treatment planning for international patients with kidney, diabetes and cardiovascular health needs.

Side Effects and Important Safety Considerations

The most important potential side effect of Kerendia is hyperkalemia, meaning a high potassium level in the blood. Potassium is necessary for normal nerve and muscle function, including the heartbeat, but excessive levels can be harmful. High potassium may cause no symptoms, which is why scheduled blood testing is so important.

Possible symptoms that warrant prompt medical advice include unusual muscle weakness, tingling, nausea, a racing or irregular heartbeat, or feeling faint. These symptoms can have many causes, but they should not be ignored, especially by someone taking a medicine that can raise potassium.

Kerendia can interact with other prescription medicines, over-the-counter products and herbal supplements. In particular, medicines that increase potassium or affect specific liver enzymes may require avoidance, dose adjustment or closer monitoring. Patients should provide their doctor and pharmacist with a complete, current medication list.

Grapefruit and grapefruit juice can affect the way some medicines are processed and may not be appropriate with finerenone. Potassium-containing salt substitutes should also not be used routinely without medical advice. People who are pregnant, planning pregnancy or breastfeeding should discuss the potential benefits and risks with their clinician, as safety information may be limited.

Supporting Kidney and Heart Health Alongside Kerendia

Medication works best when paired with a personalized long-term health plan. For people with type 2 diabetes and CKD, this usually includes monitoring blood pressure, blood glucose, kidney function and urine albumin. A clinician may recommend dietary changes, physical activity suited to the person’s abilities, weight management where appropriate and smoking cessation support.

A kidney-friendly eating plan is individual. Some people need advice on sodium, protein, potassium or fluid intake, but restrictions should not be applied without professional guidance because needs change according to kidney function, laboratory results and other illnesses. A registered dietitian can help create a practical plan that supports diabetes and kidney care.

Nonsteroidal anti-inflammatory drugs, often called NSAIDs, can affect kidney function in some people. Patients should ask a healthcare professional before using these medicines regularly, particularly if they have CKD or take several blood pressure or kidney medicines. Avoiding dehydration during illness and seeking advice when vomiting or diarrhea persists can also help protect kidney function.

Regular care for type 2 diabetes remains central. Kerendia does not replace glucose-lowering treatment, blood pressure medicines or cholesterol management when these are clinically indicated.

When to Seek Medical Care

Patients should contact their prescribing clinician promptly if they develop symptoms that could suggest high potassium, such as marked weakness, palpitations, persistent nausea, fainting or an unusual heartbeat. Urgent medical assessment is appropriate for chest pain, severe shortness of breath, collapse, confusion or a sustained irregular heartbeat.

Medical advice is also important after significant vomiting, diarrhea, poor fluid intake or an acute illness, as these situations can affect kidney function and electrolyte balance. The clinician may advise blood testing or give temporary medication instructions based on the individual situation. Patients should not make changes independently unless they have been given a specific sick-day plan.

Routine follow-up should be arranged if swelling increases, blood pressure readings are repeatedly outside the target set by the care team, urine output changes significantly, or diabetes control becomes more difficult. Early review helps clinicians identify reversible causes and adjust treatment safely.

Frequently asked questions

What is Kerendia mainly used for?

Kerendia is mainly used in eligible adults with chronic kidney disease associated with type 2 diabetes. It is intended to reduce the risk of kidney disease progression and certain cardiovascular complications. The exact approved uses may differ between countries.

Is Kerendia a diabetes medication?

Kerendia is not primarily used to lower blood glucose. It helps address kidney and cardiovascular risks linked to type 2 diabetes and chronic kidney disease. Patients usually continue their prescribed diabetes treatment unless their clinician advises otherwise.

Does Kerendia improve kidney function?

Kerendia is used to help slow the progression of kidney damage and reduce important kidney-related risks in appropriate patients. It may not produce a noticeable improvement in day-to-day symptoms or laboratory values. Regular kidney testing is needed to monitor treatment safely.

Why are potassium tests needed with Kerendia?

Kerendia can raise the potassium level in the blood. Because high potassium may not cause early symptoms, blood tests help the clinician decide whether it is safe to start, continue or adjust treatment. Monitoring is especially important after starting the medicine or changing the dose.

Can Kerendia be taken with blood pressure medicines?

It can often be used with blood pressure medicines, but the combination should be reviewed by the prescribing clinician. Some medicines can increase potassium or affect kidney function, so blood tests and medication review are important. Patients should not stop blood pressure treatment without medical guidance.

What should patients avoid while taking Kerendia?

Patients should avoid starting new medicines, herbal products, potassium supplements or potassium-containing salt substitutes without checking with a clinician or pharmacist. Grapefruit products may also be unsuitable because they can affect finerenone levels. A complete medication review helps prevent harmful interactions.

References

• U.S. Food and Drug Administration
• National Institute of Diabetes and Digestive and Kidney Diseases
• National Kidney Foundation
• American Diabetes Association
• European Medicines Agency

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.